Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?
- 1 May 2002
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (9) , 2215-2216
- https://doi.org/10.1200/jco.2002.20.9.2215
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Measuring Health-Related Quality of Life in Patients With Hepatobiliary Cancers: The Functional Assessment of Cancer Therapy–Hepatobiliary QuestionnaireJournal of Clinical Oncology, 2002
- Dexamethasone for the Prophylaxis of Radiation-Induced Emesis: A National Cancer Institute of Canada Clinical Trials Group Phase III StudyJournal of Clinical Oncology, 2000
- Missing quality of life data in cancer clinical trials: serious problems and challengesStatistics in Medicine, 1998
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993
- Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trialsQuality of Life Research, 1992
- Methodologic issues in assessing the quality of life of cancer patientsCancer, 1991
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.Journal of Clinical Oncology, 1984
- Karnofsky performance status revisited: reliability, validity, and guidelines.Journal of Clinical Oncology, 1984